Clinical Trials Logo
  1. Home
  2. Non-Hodgkin's Lymphoma (NHL)
  3. NCT01448928

Zevalin Post-marketing Surveillance in Japan — ZEVALIN-DUI  

Non-Hodgkin's Lymphoma (NHL) Clinical Trial

Official title:
Drug Use Investigation of Zevalin

Clinical Trial Summary

This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Zevalin for relapsed or refractory, CD20+, low grade B-cell non-Hodgkin's lymphoma and Mantle cell lymphoma. The objective of this study is to assess safety and efficacy of using Zevalin in clinical practice. This study is also all case investigation of which the enrollment period is five years, and all patients who received Zevalin will be recruited and followed 13 weeks after the administration.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01448928
Study type Observational
Source Spectrum Pharmaceuticals, Inc
Contact
Status Completed
Phase
Start date September 2008
Completion date January 31, 2018
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00089284 - Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL Phase 1/Phase 2
Unknown status NCT01983761 - Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation Phase 1/Phase 2
Recruiting NCT01758042 - Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders N/A
Terminated NCT00185679 - Haploid Allogeneic Transplant Using the CliniMACS System Phase 2
Completed NCT01108341 - Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL) Phase 2
Completed NCT00129090 - Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma Phase 3
Completed NCT01527838 - Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit Phase 1
Completed NCT00614042 - Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma Phase 1
Completed NCT00923910 - Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood Phase 1/Phase 2
Completed NCT02071888 - Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors Phase 1
Recruiting NCT04696705 - Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients Early Phase 1
Completed NCT01479387 - Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan N/A
Completed NCT00889798 - Tumor Registry of Lymphatic Neoplasia
Terminated NCT05144347 - Study of XL114 in Subjects With Non-Hodgkin's Lymphoma Phase 1